IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

NCT05339581 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Liver Transplant; Complications
Hepatocellular Carcinoma
Portal Vein Thrombosis
Radiotherapy; Complications

Interventions

RADIATION: intensity-modulated radiotherapy
COMBINATION_PRODUCT: Pembrolizumab
DRUG: Sintilimab
DRUG: Camrelizumab
DRUG: Tislelizumab
DRUG: Lenvatinib Mesylate Capsule

Sponsor

RenJi Hospital